These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 16199151

  • 1. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, Frost FJ.
    Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
    [Abstract] [Full Text] [Related]

  • 2. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 3. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 4. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
    Gagnon YM, Levy AR, Spencer MD, Hurley JS, Frost FJ, Mapel DW, Briggs AH.
    Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
    [Abstract] [Full Text] [Related]

  • 5. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 6. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA, Bettoncelli G, Testi R, Viegi G.
    Respir Med; 2005 Sep 10; 99(9):1115-24. PubMed ID: 15921904
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA, Fabbri LM, Davis KJ, Soriano JB.
    Respir Med; 2009 Jan 10; 103(1):85-90. PubMed ID: 18793832
    [Abstract] [Full Text] [Related]

  • 8. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
    Clin Ther; 2009 Nov 10; 31(11):2574-83. PubMed ID: 20110003
    [Abstract] [Full Text] [Related]

  • 9. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC, Lau H, La HO, Choi IS, Geba GP.
    Curr Med Res Opin; 2010 Feb 10; 26(2):297-306. PubMed ID: 19961283
    [Abstract] [Full Text] [Related]

  • 10. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul 10; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 11. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 10; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 12. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
    Curr Med Res Opin; 2009 Sep 10; 25(9):2251-8. PubMed ID: 19622006
    [Abstract] [Full Text] [Related]

  • 13. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 10; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 10; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 15. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug 10; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 16. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 17. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA.
    Pulm Pharmacol Ther; 2008 Oct 06; 21(3):540-50. PubMed ID: 18280761
    [Abstract] [Full Text] [Related]

  • 18. Inhaled corticosteroids in COPD: a controversy.
    Barnes PJ.
    Respiration; 2010 Oct 06; 80(2):89-95. PubMed ID: 20501985
    [Abstract] [Full Text] [Related]

  • 19. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN, Broeders ME, Tuut MK, Grol MH.
    Ned Tijdschr Geneeskd; 2008 Jun 28; 152(26):1465-8. PubMed ID: 18666664
    [Abstract] [Full Text] [Related]

  • 20. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC.
    Respir Med; 2017 Sep 28; 130():75-84. PubMed ID: 29206637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.